Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms, Second Primary × Trastuzumab × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 27 Neoplasms 4 Cardiotoxicity 4 Stomach Neoplasms 3 Neurotoxicity Syndromes 1 Neoplasms, Second Primary 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 HER2-positive Breast Cancer 1 HER2+ Breast Cancer 1 Feasibility 1 Fatigue 1 Breast Cancer Organoids 1 Brain Neoplasms 1

Interventions

Drug Therapy 2 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Semen Analysis 1 Registries 1 Radiotherapy 1 Patient Reported Outcome Measures 1 Lenalidomide 1 Interviews as Topic 1 Data Collection 1 Cisplatin 1 Choledochostomy 1 Bleomycin 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03199300 2025-12-11

InvestiCAT

University Medical Center Groningen

Active not recruiting

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡